Literature DB >> 15107488

Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene.

Hyun Jin Kwun1, Kyung Lib Jang.   

Abstract

Despite the extensive studies on the roles of hepatitis B virus X protein (HBx), the effects of HBx on the important cellular processes such as cell growth, cell transformation and apoptosis remain controversial. Our previous study showed that the balance between p53-dependent activation and p53-independent repression by HBx determines the expression level of cyclin-dependent kinase inhibitor p21. In the present study, we further demonstrate that HBx natural variants have differential effects on p21 expression. The critical sites in HBx were identified as residues Ser-101 for activation and Met-130 for repression, respectively. The HBx variants with Ser-101 instead of Pro-101 stabilized p53 more efficiently, probably by protecting it from the MDM2-mediated degradation. On the other hand, the Met-130-containing HBx strongly repressed p21 expression by inhibiting Sp1 activity. Overall, the effect of HBx on p21 expression seems to be determined by the balance between the opposite activities. Depending on their potentials to regulate p21 expression, HBx variants showed different effects on the cell cycle progression, and eventually on the cell growth rate, implicating its biological significance. The present study may provide a clue to explaining the contradictory results related to cell growth regulation by HBx as well as to understanding the progression of hepatic diseases in HBV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107488      PMCID: PMC407832          DOI: 10.1093/nar/gkh553

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

Review 1.  Checkpoint genes in cancer.

Authors:  E R McDonald; W S El-Deiry
Journal:  Ann Med       Date:  2001-03       Impact factor: 4.709

Review 2.  X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.

Authors:  J Diao; R Garces; C D Richardson
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

3.  Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis.

Authors:  S Sohn; I Jaitovitch-Groisman; N Benlimame; J Galipeau; G Batist; M A Alaoui-Jamali
Journal:  Mutat Res       Date:  2000-06-30       Impact factor: 2.433

4.  Aberrant cell cycle checkpoint function in transformed hepatocytes and WB-F344 hepatic epithelial stem-like cells.

Authors:  W K Kaufmann; C I Behe; V M Golubovskaya; L L Byrd; C D Albright; K M Borchet; S C Presnell; W B Coleman; J W Grisham; G J Smith
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

5.  Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cell cycle progression in rat hepatocytes by extracellular matrix.

Authors:  M Nagaki; A Sugiyama; T Naiki; Y Ohsawa; H Moriwaki
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

6.  Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.

Authors:  S E Morgan; R Kim; P C Wang; U G Bhat; H Kusumoto; T Lu; W T Beck
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

7.  Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.

Authors:  U S Park; S K Park; Y I Lee; J G Park; Y I Lee
Journal:  Oncogene       Date:  2000-07-13       Impact factor: 9.867

8.  Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma.

Authors:  V Venard; D Corsaro; C Kajzer; J P Bronowicki; A Le Faou
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

9.  FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.

Authors:  A Yen; R Sturgill; S Varvayanis; R Chern
Journal:  Exp Cell Res       Date:  1996-11-25       Impact factor: 3.905

10.  Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.

Authors:  M Bouchard; S Giannakopoulos; E H Wang; N Tanese; R J Schneider
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

View more
  25 in total

1.  Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice.

Authors:  Malgorzata Sidorkiewicz; Jean-Philippe Jais; Guilherme Tralhao; Serban Morosan; Carlo Giannini; Nicolas Brezillon; Patrick Soussan; Oona Delpuech; Dina Kremsdorf
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 2.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 3.  Effect of transforming viruses on molecular mechanisms associated with cancer.

Authors:  Tajhal Dayaram; Susan J Marriott
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

4.  p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.

Authors:  Lingling Xian; Jing Zhao; Jia Wang; Zhou Fang; Bo Peng; Wenzhang Wang; Xiaona Ji; Long Yu
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

5.  Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.

Authors:  Jian Yan; Zhicheng Yao; Kunpeng Hu; Yuesi Zhong; Mingliang Li; Zhiyong Xiong; Meihai Deng
Journal:  Dig Dis Sci       Date:  2015-01-08       Impact factor: 3.199

Review 6.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

7.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

8.  Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.

Authors:  Yuehua Huang; Shuping Tong; Andrew W Tai; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

Review 9.  Tumor-host interactions: the role of inflammation.

Authors:  Marie-Aude Le Bitoux; Ivan Stamenkovic
Journal:  Histochem Cell Biol       Date:  2008-10-25       Impact factor: 4.304

10.  Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.

Authors:  Weidong Jiang; Xin Wei Wang; Tamar Unger; Marshonna Forgues; Jin Woo Kim; S Perwez Hussain; Elise Bowman; Elisa A Spillare; Michael M Lipsky; Jeanne M Meck; Luciane R Cavalli; Bassem R Haddad; Curtis C Harris
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.